Fas-disabling small exocyclic peptide mimetics limit apoptosis by an unexpected mechanism

AUTOR(ES)

Hasegawa, Akihiro

FONTE

National Academy of Sciences

RESUMO

Fas ligand- (FasL) mediated apoptosis is an important element of tissue-specific organ damage. We have developed biologically active small exocyclic peptide mimetics that disable apoptotic functions of Fas. The most effective mimetic binds to both its receptor and FasL with comparable affinity. In vitro, the most effective antagonist blocked FasL-induced cytotoxicity completely and specifically. In vivo, the antagonistic mimetic also prevented Concanavilin A (Con A) induced hepatitis, a CD4+ T cell-mediated animal model of liver injury. Although current approaches prevent Fas receptor signaling by excluding FasL binding to Fas, the small molecule mimetics reported here disable Fas by promoting a defective Fas-FasL receptor complex. This event desensitizes FasL-mediated apoptosis by inhibiting extracellular signal regulated kinase activity and up-regulating NF-κB.

Documentos Relacionados

• Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-xL
• Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide
• Apoptosis by a cytosolic extract from Fas-activated cells.
• p53-independent apoptosis induced by paclitaxel through an indirect mechanism
• Peptide mimetics of the thrombin-bound structure of fibrinopeptide A.